SPECT/CT in the Treatment of Differentiated Thyroid Cancer

다국어 초록 (Multilingual Abstract)

Single-photon emission computed tomography with integrated computed tomography (SPECT/CT) systems has been applied in a wide range of clinical circumstances, and differentiated thyroid cancer (DTC) is one of the most important indications of SPECT/CT imaging. In the treatment of DTC, SPECT/CT images have been reported to have many advantages over conventional planar whole-body scintigraphy based on its precise localization and characterization of abnormal foci of radioactive iodine (RAI) accumulation, influencing the staging, risk stratification, and clinical management as well as reader confidence. On the other hand, SPECT/CT has limitations including additional radiation exposure from the CT component, additional imaging time, and cost-related issues.
Each SPECT/CT image acquired at different time points throughout the management of DTC may have a different clinical meaning and significance. This review article addresses the clinical usefulness of RAI SPECT/CT images acquired during the pre-ablation period, post-therapy period, and long-term follow-up period, respectively.

참고문헌 (Reference)

1 Xue YL, "Value of(1)(3)(1)I SPECT/CT for the evaluation of differentiated thyroid cancer : a systematic review of the literature" 40 : 768-778, 2013

2 McDougall IR, "Thyroid stunning: fact or fiction?" 41 : 105-112, 2011

3 Sisson JC, "Thyroid carcinoma metastasis to skull with infringement of brain : treatment with radioiodine" 19 : 297-303, 2009

4 Prideaux AR, "Three-dimensional radiobiologic dosimetry : application of radiobiologic modeling to patient-specific 3-dimensional imagingbased internal dosimetry" 48 : 1008-1016, 2007

5 Van Nostrand D, "The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer" 19 : 849-855, 2009

6 Chen MK, "The utility of I-123 pretherapy scan in I-131 radioiodine therapy for thyroid cancer" 22 : 304-309, 2012

7 Wang H, "The role of singlephoton emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer" 33 : 49-54, 2009

8 Schlumberger MJ, "The low utility of pretherapy scans in thyroid cancer patients" 19 : 815-816, 2009

9 Grewal RK, "The effect of posttherapy 131I SPECT/CTon risk classification and management of patients with differentiated thyroid cancer" 51 : 1361-1367, 2010

10 Wong KK, "Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT" 195 : 730-736, 2010

11 Barwick T, "Single photon emission computed tomography(SPECT)/computed tomography using iodine-123 in patients with differentiated thyroid cancer : additional value over whole body planar imaging and SPECT" 162 : 1131-1139, 2010

12 Mustafa M, "Regional lymph node involvement in T1 papillary thyroid carcinoma : a bicentric prospective SPECT/CT study" 37 : 1462-1466, 2010

13 Avram AM, "Radioiodine scintigraphy with SPECT/CT : an important diagnostic tool for thyroid cancer staging and risk stratification" 53 : 754-764, 2012

14 Avram AM, "Preablation 131-I scans with SPECT/CT in postoperative thyroid cancer patients:what is the impact on staging?" 98 : 1163-1171, 2013

15 Avram AM, "Preablation 131-I scans with SPECT/CT contribute to thyroid cancer risk stratification and 131-I therapy planning" 100 : 1895-1902, 2015

16 Kohlfuerst S, "Posttherapeutic(131)I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen" 36 : 886-893, 2009

17 Ciappuccini R, "Postablation(131)I scintigraphy with neck and thorax SPECTCTand stimulated serum thyroglobulin level predict the outcome of patients with differentiated thyroid cancer" 164 : 961-969, 2011

18 Yap BK, "No adverse affect in clinical outcome using low preablation diagnostic(131)i activity in differentiated thyroid cancer : refuting thyroid-stunning effect" 99 : 2433-2440, 2014

19 Chen L, "Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma" 49 : 1952-1957, 2008

20 Maruoka Y, "Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma" 265 : 902-909, 2012

21 Ruf J, "Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma" 25 : 1177-1182, 2004

22 Tharp K, "Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma" 31 : 1435-1442, 2004

23 Schmidt D, "Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation" 50 : 18-23, 2009

24 Blum M, "I-131 SPECT/CT elucidates cryptic findings on planar whole-body scans and can reduce needless therapy with I-131 in post-thyroidectomy thyroid cancer patients" 21 : 1235-1247, 2011

25 Patton JA, "Hybrid imaging technology : from dreams and vision to clinical devices" 39 : 247-263, 2009

26 Schmidt D, "Five months’ follow-up of patients with and without iodine-positive lymph node metastases of thyroid carcinoma as disclosed by(131)I-SPECT/CT at the first radioablation" 37 : 699-705, 2010

27 Pacini F, "European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium" 154 : 787-803, 2006

28 Yamamoto Y, "Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma" 44 : 1905-1910, 2003

29 Aide N, "Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation(131)I scintigraphy for thyroid cancer" 94 : 2075-2084, 2009

30 Jeong SY, "Clinical applications of SPECT/CT after first I-131 ablation in patients with differentiated thyroid cancer" 81 : 445-451, 2014

31 Mariani G, "A review on the clinical uses of SPECT/CT" 37 : 1959-1985, 2010

32 Haugen BR, "2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer" 26 : 1-133, 2016

33 Menges M, "131I SPECT/CT in the follow-up of patients with differentiated thyroid carcinoma" 37 : 555-560, 2012

34 Spanu A, "131I SPECT/CT in the follow-up of differentiated thyroid carcinoma : incremental value versus planar imaging" 50 : 184-190, 2009